Marinus Pharma (MRNS)
1.42
-0.02 (1.39%)
Upcoming Events
Latest Headlines
Form SC 13G MARINUS PHARMACEUTICALS, Filed by: TANG CAPITAL PARTNERS LP
April 19, 2024 6:06 AM - SEC Filing
Marinus Pharmaceuticals (MRNS) PT Lowered to $10 at Truist Securities
April 17, 2024 10:54 AM - StreetInsider
Marinus Pharmaceuticals (MRNS) PT Lowered to $13 at Cantor Fitzgerald
April 16, 2024 6:31 AM - StreetInsider
Baird Downgrades Marinus Pharmaceuticals (MRNS) to Neutral, 'Phase 3 RAISE Study Doesn't Hit at Interim'
April 16, 2024 3:06 AM - StreetInsider
RBC Capital Downgrades Marinus Pharmaceuticals (MRNS) to Sector Perform
April 15, 2024 12:54 PM - StreetInsider
Marinus Pharmaceuticals (MRNS) PT Lowered to $4 at Ladenburg Thalmann
April 15, 2024 12:53 PM - StreetInsider
Form 8-K MARINUS PHARMACEUTICALS, For: Apr 15
April 15, 2024 7:32 AM - SEC Filing
Marinus Pharma (MRNS) phase 3 RAISE trial did not meet pre-defined stopping criteria at the interim analysis
April 15, 2024 7:01 AM - StreetInsider
Marinus Pharmaceuticals Provides Update on the Phase 3 RAISE Trial and Reports Preliminary First Quarter 2024 Financial Results
April 15, 2024 7:00 AM - BizWire
Marinus Pharma (MRNS) Halted, News Pending
April 15, 2024 6:55 AM - StreetInsider
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
April 5, 2024 4:00 PM - BizWire
Form DEFA14A MARINUS PHARMACEUTICALS,
April 4, 2024 8:03 AM - SEC Filing
Form DEF 14A MARINUS PHARMACEUTICALS, For: May 22
April 4, 2024 8:00 AM - SEC Filing
Oppenheimer Reiterates Perform Rating on Marinus Pharmaceuticals (MRNS)
March 28, 2024 3:28 PM - StreetInsider
Form 8-K MARINUS PHARMACEUTICALS, For: Mar 27
March 27, 2024 4:06 PM - SEC Filing
Form 4 MARINUS PHARMACEUTICALS, For: Mar 27 Filed by: Braunstein Scott
March 27, 2024 11:55 AM - SEC Filing
Marinus Pharma (MRNS) Comments on Patent Challenge by Ovid, Provides Update on Marinus’ Post Grant Review
March 27, 2024 8:41 AM - StreetInsider
Marinus Pharmaceuticals Comments on Patent Challenge by Ovid Therapeutics Inc. and Provides Update on Marinus’ Post Grant Review
March 27, 2024 8:41 AM - BizWire
DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2023 Financial Results
March 19, 2024 4:15 PM - BizWire
Form 10-K MARINUS PHARMACEUTICALS, For: Dec 31
March 5, 2024 4:15 PM - SEC Filing
Form 8-K MARINUS PHARMACEUTICALS, For: Mar 05
March 5, 2024 4:06 PM - SEC Filing
Marinus Pharma (MRNS) Misses Q4 EPS by 12c ; Offers Guidance
March 5, 2024 4:05 PM - StreetInsider
Marinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
March 5, 2024 4:01 PM - BizWire
Form 4 MARINUS PHARMACEUTICALS, For: Feb 20 Filed by: Shafer Christina
February 22, 2024 4:06 PM - SEC Filing
Form 4 MARINUS PHARMACEUTICALS, For: Feb 20 Filed by: MANNING MARTHA E
February 22, 2024 4:06 PM - SEC Filing
Form 4 MARINUS PHARMACEUTICALS, For: Feb 16 Filed by: Hulihan Joseph
February 21, 2024 4:06 PM - SEC Filing
Form 4 MARINUS PHARMACEUTICALS, For: Feb 16 Filed by: Pfanstiel Steven
February 21, 2024 4:06 PM - SEC Filing
Form 4 MARINUS PHARMACEUTICALS, For: Feb 16 Filed by: Braunstein Scott
February 21, 2024 4:05 PM - SEC Filing
Marinus Pharmaceuticals to Present at Upcoming Investor Conferences
February 21, 2024 7:00 AM - BizWire
Marinus Pharmaceuticals to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024
February 20, 2024 7:00 AM - BizWire
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
February 16, 2024 4:00 PM - BizWire
Form SC 13G/A MARINUS PHARMACEUTICALS, Filed by: Lion Point Capital, LP
February 14, 2024 4:19 PM - SEC Filing
Form SC 13G/A MARINUS PHARMACEUTICALS, Filed by: Cormorant Asset Management, LP
February 14, 2024 3:08 PM - SEC Filing
Form SC 13G/A MARINUS PHARMACEUTICALS, Filed by: EVENTIDE ASSET MANAGEMENT, LLC
February 14, 2024 12:18 PM - SEC Filing
Form SC 13G MARINUS PHARMACEUTICALS, Filed by: PRUDENTIAL FINANCIAL INC
February 14, 2024 10:36 AM - SEC Filing
Form SC 13G/A MARINUS PHARMACEUTICALS, Filed by: Point72 Asset Management, L.P.
February 14, 2024 10:08 AM - SEC Filing
Form SC 13G/A MARINUS PHARMACEUTICALS, Filed by: Avoro Capital Advisors LLC
February 14, 2024 9:04 AM - SEC Filing
Form SC 13G/A MARINUS PHARMACEUTICALS, Filed by: SUVRETTA CAPITAL MANAGEMENT, LLC
February 13, 2024 12:13 PM - SEC Filing
Form SC 13G MARINUS PHARMACEUTICALS, Filed by: JENNISON ASSOCIATES LLC
February 8, 2024 1:57 PM - SEC Filing
Form SC 13G/A MARINUS PHARMACEUTICALS, Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
February 7, 2024 7:26 AM - SEC Filing
Form SC 13G MARINUS PHARMACEUTICALS, Filed by: FRANKLIN RESOURCES INC
February 6, 2024 11:58 AM - SEC Filing
Full Article List
